Standout Papers
- Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study (2017)
- Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study (2021)
- Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 (2024)
Immediate Impact
2 from Science/Nature 68 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Long COVID science, research and policy
2024 Standout
Works of Dona Fleishaker being referenced
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19
2024 Standout
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study
2021 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Dona Fleishaker | 586 | 298 | 352 | 28 | 873 | |
| Chia‐Wei Hsieh | 397 | 326 | 408 | 44 | 1.0k | |
| Heikki Isomäki | 559 | 184 | 191 | 15 | 1.1k | |
| Raquel Cuchacovich | 612 | 297 | 532 | 29 | 979 | |
| N. J. GERBER | 475 | 122 | 264 | 29 | 970 | |
| Marjatta Sinisalo | 129 | 387 | 302 | 32 | 920 | |
| P Casassus | 494 | 158 | 68 | 22 | 1.1k | |
| Angela Midgley | 455 | 188 | 525 | 35 | 1.0k | |
| H V Bashir | 424 | 178 | 369 | 32 | 874 | |
| Ιωάννα Μαρίνου | 317 | 61 | 271 | 33 | 948 | |
| John P. Leddy | 168 | 314 | 355 | 34 | 1.1k |
All Works
Loading papers...